Cozad Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-627
Closed -$244K 422
2025
Q2
$244K Sell
627
-48
-7% -$19.3K 0.02% 379
2025
Q1
$294K Sell
675
-139
-17% -$55.8K 0.03% 328
2024
Q4
$300K Sell
814
-46
-5% -$19.2K 0.03% 328
2024
Q3
$447K Sell
860
-10
-1% -$5.34K 0.04% 271
2024
Q2
$471K Buy
870
+26
+3% +$13.7K 0.05% 265
2024
Q1
$438K Buy
844
+91
+12% +$45.3K 0.05% 270
2023
Q4
$355K Buy
753
+26
+4% +$12K 0.04% 293
2023
Q3
$317K Sell
727
-420
-37% -$191K 0.04% 290
2023
Q2
$510K Sell
1,147
-1,069
-48% -$493K 0.06% 239
2023
Q1
$1.02M Sell
2,216
-629
-22% -$299K 0.13% 168
2022
Q4
$1.46M Sell
2,845
-154
-5% -$78.2K 0.21% 132
2022
Q3
$1.36M Sell
2,999
-1,887
-39% -$903K 0.22% 125
2022
Q2
$2.36M Buy
4,886
+392
+9% +$194K 0.37% 80
2022
Q1
$2.21M Buy
4,494
+1,770
+65% +$809K 0.31% 87
2021
Q4
$1.26M Buy
2,724
+585
+27% +$246K 0.18% 137
2021
Q3
$798K Buy
2,139
+580
+37% +$220K 0.12% 170
2021
Q2
$595K Sell
1,559
-50
-3% -$19.1K 0.09% 185
2021
Q1
$578K Sell
1,609
-70
-4% -$22.5K 0.09% 192
2020
Q4
$539K Sell
1,679
-25
-1% -$7.67K 0.1% 190
2020
Q3
$458K Sell
1,704
-7
-0.4% -$1.88K 0.09% 203
2020
Q2
$450K Sell
1,711
-40
-2% -$10.7K 0.09% 194
2020
Q1
$398K Sell
1,751
-60
-3% -$16.4K 0.14% 143
2019
Q4
$547K Hold
1,811
0.15% 138
2019
Q3
$435K Sell
1,811
-17
-0.9% -$4.66K 0.13% 156
2019
Q2
$516K Sell
1,828
-19
-1% -$5.19K 0.15% 140
2019
Q1
$530K Sell
1,847
-100
-5% -$28.9K 0.16% 136
2018
Q4
$511K Sell
1,947
-155
-7% -$42.6K 0.18% 131
2018
Q3
$576K Buy
2,102
+37
+2% +$9.61K 0.17% 127
2018
Q2
$491K Buy
+2,065
New +$478K 0.15% 135

Other funds holding ELV

Cozad Asset Management's ELV Position: Q3 2025 in Review

Cozad Asset Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 627 shares — an estimated $244K sold.

Cozad Asset Management first reported a position in ELV in Q2 2018 and held it in 29 quarters. The position peaked at $2.36M in Q2 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Cozad Asset Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Cozad Asset Management sold 627 Elevance Health shares in Q3 2025, an estimated $244K.
  • Cozad Asset Management first reported a position in Elevance Health in Q2 2018 and held it in 29 quarters.
  • Cozad Asset Management's Elevance Health position peaked at $2.36M in Q2 2022.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Cozad Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.